General News | Neopharm Group

Advil – a Superbrand in Israel

December 25, 2012

2012 marks the third year Advil has won “Superbrand” status in the healthcare arena in Israel. This…

Eisai’s Halaven® Approved In Israel

July 12, 2012

HATFIELD, UK 10 July 2012 – Halaven® (eribulin), a novel treatment for patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease, has recently received…

Sativex® receives regulatory approval in Israel

June 13, 2012

Neopharm Group and GW Pharmaceuticals plc announced that Sativex® (Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) oromucosal spray) has received regulatory approval from the Israeli Ministry of Health for the treatment of spasticity and neuropathic pain due…

Promedico Receives “Best Employer” Honor from AKIM

Promedico, a part of Neopharm Group, received the “Best Employer” prize for 2012 for its employment program of mentally handicapped adults. The prize was presented at a special ceremony organized by AKIM and IKEA where…

News and Updates

Advil – a Superbrand in Israel

Eisai’s Halaven® Approved In Israel

Sativex® receives regulatory approval in Israel

Promedico Receives “Best Employer” Honor from AKIM

Group Companies